Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New lupus drug candidate enters first human safety tests

NCT ID NCT06144710

First seen Mar 28, 2026 · Last updated Apr 30, 2026 · Updated 4 times

Summary

This early-stage study tests an experimental injection called SG301 in 48 people. First, healthy volunteers receive a single dose to check safety. Then, people with systemic lupus erythematosus (SLE) receive multiple doses. The main goal is to see if the drug is safe and how the body processes it.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • First Affiliated Hospital of Xiamen University

    Xiamen, Fujian, 361003, China

  • Huashan Hospital affiliated to Fudan University

    Shanghai, Shanghai Municipality, 200040, China

  • Jiangxi Provincial People's Hospital

    Nanchang, Jiangxi, 330006, China

  • Jining First People's Hospital

    Jining, Shandong, 272002, China

  • Pingxiang People's Hospital

    Pingxiang, Jiangxi, 337099, China

  • Shandong University Qilu Hospital

    Jinan, Shandong, 250063, China

  • Shenzhen People's Hospital

    Shenzhen, Guangdong, 518020, China

  • The First Affiliated Hospital of Bengbu Medical College

    Bengbu, Anhui, 233000, China

  • The First Affiliated Hospital of Fujian Medical University

    Fuzhou, Fujian, 350004, China

  • Zhejiang Provincial People's Hospital

    Hangzhou, Zhejiang, 314408, China

Conditions

Explore the condition pages connected to this study.